KP Tissue Inc. (KPTSF) Comparison with companies in other sectors?

KP Tissue Inc. has a share price of 10.00M. You can analyze KP Tissue Inc. (KPTSF) competitors across different market sectors through stock heatmaps.

What are KPTSF's NET and operating margins?

KP Tissue Inc. (KPTSF) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does KPTSF's earnings per share (EPS) trend reflect its financial momentum?

KP Tissue Inc. (KPTSF) EPS is 0.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for KP Tissue Inc. is 29.60, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for KP Tissue Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for KP Tissue Inc. like P/E which is 36.60, P/B which is 1.28, and PEG which is -0.47. Compare them with sector averages to evaluate if the stock is priced fairly.

KP Tissue Inc.

KPTSF•PNK

Consumer Defensive

Household & Personal Products

$6.51

$-0.00(-0.03%)

Fundamental Analysis of KP Tissue Inc. (KPTSF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.22

P/E Ratio

29.60

ROE

0.03%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$65.13M

Shares OutstandingTotal number of shares issued

$10.00M

Book Value/ShareNet worth per share

$6.97

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.22

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

3.44%

ROAReturn on total assets

3.41%

ROCEReturn on capital employed

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.35

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

3.92%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.70

Dividend YieldAnnual dividend as percentage of stock price

7.87%

Financial Ratios Analysis data is not available for KPTSFFinancial Ratios Analysis details for KPTSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for KPTSFSector Benchmarking details for KPTSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for KP Tissue Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of KP Tissue Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account KP Tissue Inc.'s unique business strengths and challenges.

Key Financial Metrics for KP Tissue Inc.

For KP Tissue Inc., essential financial indicators include EPS 0.22, PE 29.60, and ROE 0.03. These key ratios reveal insights into KP Tissue Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare KP Tissue Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of KP Tissue Inc.

Metrics like Net Margin - and ROA 3.41% shed light on how well KP Tissue Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether KP Tissue Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of KP Tissue Inc.

Using ratios such as P/B Ratio 1.28 and PEG Ratio -0.47, investors can assess whether KP Tissue Inc. is appropriately valued based on its financials and growth potential. These figures, combined with KP Tissue Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for KP Tissue Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $0.35, provide a snapshot of KP Tissue Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like KP Tissue Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for KP Tissue Inc.

Investing in KP Tissue Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at KP Tissue Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;